Literature DB >> 3096690

Prolactin messenger ribonucleic acid levels in the normal and hypogonadal mouse pituitary gland.

H F Stanley, A Curtis, W J Sheward, J L Roberts, G Fink.   

Abstract

The effects of estrogen on the synthesis of pituitary PRL mRNA and PRL and the release of PRL into plasma were investigated in male and female normal and hypogonadal (hpg) mice. Because the hpg mouse is totally deficient in hypothalamic GnRH, it provides an excellent model for investigating the effects of estrogen and GnRH on PRL synthesis and release in the presence of a totally inactive gonadotropin-gonadal system. Estrogen stimulated the synthesis and release of pituitary PRL in both sexes of normal and hpg mice, and this marked increase in PRL synthesis correlated with an equally dramatic increase in pituitary PRL mRNA levels. Administration of GnRH alone produced a slight but significant increase in pituitary PRL content, which is consistent with an action of GnRH on prolactotropes, either directly or by way of a paracrine action involving gonadotropes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096690     DOI: 10.1210/endo-119-6-2422

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Combined use of in situ hybridisation and immunocytochemistry for the investigation of prolactin gene expression in immature, pubertal, pregnant, lactating and ovariectomised rats.

Authors:  J H Steel; Q Hamid; S Van Noorden; P Jones; P Denny; J Burrin; S Legon; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1988

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

3.  Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.

Authors:  Shameena Bake; Lijiang Ma; Farida Sohrabji
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.